Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses

Journal of Molecular Biology

Volumn 428, Issue 17, 2016, Pages 3467-3482

  Chatterjee, Srirupa ^a   Basler, Christopher F ^b   Amarasinghe, Gaya K ^a   Leung, Daisy W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

innate immune evasion; interferon antagonist; Mononegavirales; viral antagonism

Indexed keywords

INTERFERON; INTERFERON REGULATORY FACTOR 3; JANUS KINASE; PROTEIN KINASE R; PROTEIN KINASE R ACTIVATOR; RECEPTOR ACTIVITY MODIFYING PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; STAT PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; VIRUS RNA;

CYTOKINE RESPONSE; ENZYME PHOSPHORYLATION; GENE; GENOME ANALYSIS; HOST RESISTANCE; HUMAN; IMMUNE EVASION; IMMUNOMODULATION; INNATE IMMUNITY; INTERFERON STIMULATED GENE; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NEGATIVE-STRAND RNA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN INDUCTION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; VIRUS GENOME; VIRUS INFECTION; VIRUS INHIBITION; ANIMAL; BIOLOGICAL MODEL; HOST PATHOGEN INTERACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MOLECULAR MODEL; MONONEGAVIRALES; PATHOGENICITY;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; IMMUNITY, INNATE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MONONEGAVIRALES;

EID: 84984582298     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2016.07.017     Document Type: Review

References (127)

1. [1] Gerlier, D., Lyles, D.S., Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol. Mol. Biol. Rev. 75 (2011), 468–490 (second page of table of contents).
2. [2] Ortin, J., Martin-Benito, J., The RNA synthesis machinery of negative-stranded RNA viruses. Virology 479–480 (2015), 532–544.
3. [3] Poenisch, M., Burger, N., Staeheli, P., Bauer, G., Schneider, U., Protein X of Borna disease virus inhibits apoptosis and promotes viral persistence in the central nervous systems of newborn-infected rats. J. Virol. 83 (2009), 4297–4307.
4. [4] Herrel, M., Hoefs, N., Staeheli, P., Schneider, U., Tick-borne Nyamanini virus replicates in the nucleus and exhibits unusual genome and matrix protein properties. J. Virol. 86 (2012), 10,739–10,747.
5. [5] Poenisch, M., Wille, S., Ackermann, A., Staeheli, P., Schneider, U., The X protein of Borna disease virus serves essential functions in the viral multiplication cycle. J. Virol. 81 (2007), 7297–7299.
6. [6] Wensman, J.J., Munir, M., Thaduri, S., Hornaeus, K., Rizwan, M., Blomstrom, A.L., et al. The X proteins of bornaviruses interfere with type I interferon signalling. J Gen Virol. 94 (2013), 263–269.
7. [7] Lo, M.S., Brazas, R.M., Holtzman, M.J., Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79 (2005), 9315–9319.
8. [8] Goswami, R., Majumdar, T., Dhar, J., Chattopadhyay, S., Bandyopadhyay, S.K., Verbovetskaya, V., et al. Viral degradasome hijacks mitochondria to suppress innate immunity. Cell Res. 23 (2013), 1025–1042.
9. [9] Alcami, A., Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3 (2003), 36–50.
10. [10] Akira, S., Uematsu, S., Takeuchi, O., Pathogen recognition and innate immunity. Cell 124 (2006), 783–801.
11. [11] Leung, D.W., Basler, C.F., Amarasinghe, G.K., Molecular mechanisms of viral inhibitors of RIG-I-like receptors. Trends Microbiol. 20 (2012), 139–146.
12. [12] Takeuchi, O., Akira, S., MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 20 (2008), 17–22.
13. [13] Schlee, M., Roth, A., Hornung, V., Hagmann, C.A., Wimmenauer, V., Barchet, W., et al. Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31 (2009), 25–34.
14. [14] Yoneyama, M., Kikuchi, M., Matsumoto, K., Imaizumi, T., Miyagishi, M., Taira, K., et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175 (2005), 2851–2858.
15. [15] Schmidt, A., Schwerd, T., Hamm, W., Hellmuth, J.C., Cui, S., Wenzel, M., et al. 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 12,067–12,072.
16. [16] Li, X., Lu, C., Stewart, M., Xu, H., Strong, R.K., Igumenova, T., et al. Structural basis of double-stranded RNA recognition by the RIG-I like receptor MDA5. Arch. Biochem. Biophys. 488 (2009), 23–33.
17. [17] Akira, S., Takeda, K., Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004), 499–511.
18. [18] Sun, Q., Sun, L., Liu, H.H., Chen, X., Seth, R.B., Forman, J., et al. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24 (2006), 633–642.
19. [19] Berke, I.C., Modis, Y., MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA. EMBO J. 31 (2012), 1714–1726.
20. [20] Yan, N., Chen, Z.J., Intrinsic antiviral immunity. Nat. Immunol. 13 (2012), 214–222.
21. [21] Kawai, T., Akira, S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11 (2010), 373–384.
22. [22] Leung, D.W., Shabman, R.S., Farahbakhsh, M., Prins, K.C., Borek, D.M., Wang, T., et al. Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain. J. Mol. Biol. 399 (2010), 347–357.
23. [23] Ramanan, P., Edwards, M.R., Shabman, R.S., Leung, D.W., Endlich-Frazier, A.C., Borek, D.M., et al. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 20,661–20,666.
24. [24] Prins, K.C., Delpeut, S., Leung, D.W., Reynard, O., Volchkova, V.A., Reid, S.P., et al. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. J. Virol. 84 (2010), 3004–3015.
25. [25] Peisley, A., Lin, C., Wu, B., Orme-Johnson, M., Liu, M., Walz, T., et al. Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 21,010–21,015.
26. [26] Edwards, M.R., Liu, G., Mire, C.E., Sureshchandra, S., Luthra, P., Yen, B., et al. Differential regulation of interferon responses by Ebola and Marburg virus VP35 proteins. Cell Rep. 14 (2016), 1632–1640.
27. [27] Motz, C., Schuhmann, K.M., Kirchhofer, A., Moldt, M., Witte, G., Conzelmann, K.K., et al. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science 339 (2013), 690–693.
28. [28] Andrejeva, J., Childs, K.S., Young, D.F., Carlos, T.S., Stock, N., Goodbourn, S., et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 17,264–17,269.
29. [29] Childs, K., Randall, R., Goodbourn, S., Paramyxovirus V proteins interact with the RNA helicase LGP2 to inhibit RIG-I-dependent interferon induction. J. Virol. 86 (2012), 3411–3421.
30. [30] Parisien, J.P., Bamming, D., Komuro, A., Ramachandran, A., Rodriguez, J.J., Barber, G., et al. A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. J. Virol. 83 (2009), 7252–7260.
31. [31] Childs, K., Stock, N., Ross, C., Andrejeva, J., Hilton, L., Skinner, M., et al. Mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359 (2007), 190–200.
32. [32] Wu, B., Hur, S., How RIG-I like receptors activate MAVS. Curr. Opin. Virol. 12 (2015), 91–98.
33. [33] Boyapalle, S., Wong, T., Garay, J., Teng, M., San Juan-Vergara, H., Mohapatra, S., et al. Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection. PLoS One, 7, 2012, e29386.
34. [34] Ling, Z., Tran, K.C., Teng, M.N., Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J. Virol. 83 (2009), 3734–3742.
35. [35] Gack, M.U., Nistal-Villan, E., Inn, K.S., Garcia-Sastre, A., Jung, J.U., Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J. Virol. 84 (2010), 3220–3229.
36. [36] Loo, Y.M., Gale, M. Jr., Immune signaling by RIG-I-like receptors. Immunity 34 (2011), 680–692.
37. [37] Wies, E., Wang, M.K., Maharaj, N.P., Chen, K., Zhou, S., Finberg, R.W., et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 38 (2013), 437–449.
38. [38] Davis, M.E., Wang, M.K., Rennick, L.J., Full, F., Gableske, S., Mesman, A.W., et al. Antagonism of the phosphatase PP1 by the measles virus V protein is required for innate immune escape of MDA5. Cell Host Microbe 16 (2014), 19–30.
39. [39] Lu, L.L., Puri, M., Horvath, C.M., Sen, G.C., Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKε)/TBK1. J. Biol. Chem. 283 (2008), 14,269–14,276.
40. [40] Ludlow, L.E., Lo, M.K., Rodriguez, J.J., Rota, P.A., Horvath, C.M., Henipavirus V protein association with Polo-like kinase reveals functional overlap with STAT1 binding and interferon evasion. J. Virol. 82 (2008), 6259–6271.
41. [41] Pfaller, C.K., Conzelmann, K.K., Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction. J. Virol. 82 (2008), 12,365–12,373.
42. [42] Shiell, B.J., Gardner, D.R., Crameri, G., Eaton, B.T., Michalski, W.P., Sites of phosphorylation of P and V proteins from Hendra and Nipah viruses: newly emerged members of Paramyxoviridae. Virus Res. 92 (2003), 55–65.
43. [43] Kok, K.H., Lui, P.Y., Ng, M.H., Siu, K.L., Au, S.W., Jin, D.Y., The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 9 (2011), 299–309.
44. [44] Iwamura, T., Yoneyama, M., Koizumi, N., Okabe, Y., Namiki, H., Samuel, C.E., et al. PACT, a double-stranded RNA binding protein acts as a positive regulator for type I interferon gene induced by Newcastle disease virus. Biochem. Biophys. Res. Commun. 282 (2001), 515–523.
45. [45] Luthra, P., Ramanan, P., Mire, C.E., Weisend, C., Tsuda, Y., Yen, B., et al. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 14 (2013), 74–84.
46. [46] Prins, K.C., Binning, J.M., Shabman, R.S., Leung, D.W., Amarasinghe, G.K., Basler, C.F., Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function. J. Virol. 84 (2010), 10,581–10,591.
47. [47] Becker, S., Rinne, C., Hofsass, U., Klenk, H.D., Muhlberger, E., Interactions of Marburg virus nucleocapsid proteins. Virology 249 (1998), 406–417.
48. [48] Unterstab, G., Ludwig, S., Anton, A., Planz, O., Dauber, B., Krappmann, D., et al. Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 13.640–13.645.
49. [49] Brzozka, K., Finke, S., Conzelmann, K.K., Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 79 (2005), 7673–7681.
50. [50] Prins, K.C., Cardenas, W.B., Basler, C.F., Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J. Virol. 83 (2009), 3069–3077.
51. [51] Irie, T., Kiyotani, K., Igarashi, T., Yoshida, A., Sakaguchi, T., Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein. J. Virol. 86 (2012), 7136–7145.
52. [52] Chang, T.H., Kubota, T., Matsuoka, M., Jones, S., Bradfute, S.B., Bray, M., et al. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog., 5, 2009, e1000493.
53. [53] Rawlings, J.S., Rosler, K.M., Harrison, D.A., The JAK/STAT signaling pathway. J. Cell Sci. 117 (2004), 1281–1283.
54. [54] O'Shea, J.J., Schwartz, D.M., Villarino, A.V., Gadina, M., McInnes, I.B., Laurence, A., The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu. Rev. Med. 66 (2015), 311–328.
55. [55] Ivashkiv, L.B., Donlin, L.T., Regulation of type I interferon responses. Nat. Rev. Immunol. 14 (2014), 36–49.
56. [56] KTCaMG, J., Snapshot: interferon signaling. Cell, 163, 2015, 1808.
57. [57] McBride, K.M., Banninger, G., McDonald, C., Reich, N.C., Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-alpha. EMBO J. 21 (2002), 1754–1763.
58. [58] Sekimoto, T., Imamoto, N., Nakajima, K., Hirano, T., Yoneda, Y., Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1. EMBO J. 16 (1997), 7067–7077.
59. [59] Schneider, W.M., Chevillotte, M.D., Rice, C.M., Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32 (2014), 513–545.
60. [60] Sadler, A.J., Williams, B.R., Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8 (2008), 559–568.
61. [61] Haller, O., Staeheli, P., Schwemmle, M., Kochs, G., Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol. 23 (2015), 154–163.
62. [62] Garcia, M.A., Gil, J., Ventoso, I., Guerra, S., Domingo, E., Rivas, C., et al. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70 (2006), 1032–1060.
63. [63] Rebouillat, D., Hovanessian, A.G., The human 2′,5′-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J. Interf. Cytokine Res. 19 (1999), 295–308.
64. [64] Diamond, M.S., Farzan, M., The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13 (2013), 46–57.
65. [65] Vladimer, G.I., Gorna, M.W., Superti-Furga, G., IFITs: emerging roles as key anti-viral proteins. Front. Immunol., 5, 2014, 94.
66. [66] Ozato, K., Shin, D.M., Chang, T.H., Morse, H.C. 3rd., TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8 (2008), 849–860.
67. [67] Kuhl, A., Banning, C., Marzi, A., Votteler, J., Steffen, I., Bertram, S., et al. The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin. J. Infect. Dis. 204 (2011), S850–S860.
68. [68] Valmas, C., Grosch, M.N., Schumann, M., Olejnik, J., Martinez, O., Best, S.M., et al. Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathog., 6, 2010, e1000721.
69. [69] Shaw, M.L., Garcia-Sastre, A., Palese, P., Basler, C.F., Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J. Virol. 78 (2004), 5633–5641.
70. [70] Oda, K., Matoba, Y., Irie, T., Kawabata, R., Fukushi, M., Sugiyama, M., et al. Structural basis of the inhibition of STAT1 activity by Sendai virus C protein. J. Virol. 89 (2015), 11,487–11,499.
71. [71] Gotoh, B., Komatsu, T., Takeuchi, K., Yokoo, J., The C-terminal half-fragment of the Sendai virus C protein prevents the gamma-activated factor from binding to a gamma-activated sequence site. Virology 316 (2003), 29–40.
72. [72] Gotoh, B., Takeuchi, K., Komatsu, T., Yokoo, J., The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J. Virol. 77 (2003), 3360–3370.
73. [73] Takeuchi, K., Komatsu, T., Yokoo, J., Kato, A., Shioda, T., Nagai, Y., et al. Sendai virus C protein physically associates with Stat1. Genes Cells. 6 (2001), 545–557.
74. [74] Reid, S.P., Leung, L.W., Hartman, A.L., Martinez, O., Shaw, M.L., Carbonnelle, C., et al. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J. Virol. 80 (2006), 5156–5167.
75. [75] Reid, S.P., Valmas, C., Martinez, O., Sanchez, F.M., Basler, C.F., Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J. Virol. 81 (2007), 13,469–13,477.
76. [76] Xu, W., Edwards, M.R., Borek, D.M., Feagins, A.R., Mittal, A., Alinger, J.B., et al. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe 16 (2014), 187–200.
77. [77] Conti, E., Uy, M., Leighton, L., Blobel, G., Kuriyan, J., Crystallographic analysis of the recognition of a nuclear localization signal by the nuclear import factor karyopherin alpha. Cell 94 (1998), 193–204.
78. [78] Conti, E., Kuriyan, J., Crystallographic analysis of the specific yet versatile recognition of distinct nuclear localization signals by karyopherin alpha. Structure 8 (2000), 329–338.
79. [79] Chook, Y.M., Blobel, G., Karyopherins and nuclear import. Curr. Opin. Struct. Biol. 11 (2001), 703–715.
80. [80] Conti, E., Izaurralde, E., Nucleocytoplasmic transport enters the atomic age. Curr. Opin. Cell Biol. 13 (2001), 310–319.
81. [81] Wiltzer, L., Okada, K., Yamaoka, S., Larrous, F., Kuusisto, H.V., Sugiyama, M., et al. Interaction of rabies virus P-protein with STAT proteins is critical to lethal rabies disease. J. Infect. Dis. 209 (2014), 1744–1753.
82. [82] Pindel, A., Sadler, A., The role of protein kinase R in the interferon response. J. Interf. Cytokine Res. 31 (2011), 59–70.
83. [83] Feng, Z., Cerveny, M., Yan, Z., He, B., The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J. Virol. 81 (2007), 182–192.
84. [84] Schumann, M., Gantke, T., Muhlberger, E., Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J. Virol. 83 (2009), 8993–8997.
85. [85] Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., Banting, G., Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4 (2003), 694–709.
86. [86] Jouvenet, N., Neil, S.J., Zhadina, M., Zang, T., Kratovac, Z., Lee, Y., et al. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J. Virol. 83 (2009), 1837–1844.
87. [87] Gupta, R.K., Mlcochova, P., Pelchen-Matthews, A., Petit, S.J., Mattiuzzo, G., Pillay, D., et al. Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 20,889–20,894.
88. [88] Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I.B., et al. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog., 5, 2009, e1000429.
89. [89] Le Tortorec, A., Neil, S.J., Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 83 (2009), 11,966–11,978.
90. [90] Sakuma, T., Noda, T., Urata, S., Kawaoka, Y., Yasuda, J., Inhibition of Lassa and Marburg virus production by tetherin. J. Virol. 83 (2009), 2382–2385.
91. [91] Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M.W., Gregory, D.A., Johnson, M.C., et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell. 139 (2009), 499–511.
92. [92] Kaletsky, R.L., Francica, J.R., Agrawal-Gamse, C., Bates, P., Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 2886–2891.
93. [93] Neil, S.J., Sandrin, V., Sundquist, W.I., Bieniasz, P.D., An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2 (2007), 193–203.
94. [94] Lopez, L.A., Yang, S.J., Hauser, H., Exline, C.M., Haworth, K.G., Oldenburg, J., et al. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal. J. Virol. 84 (2010), 7243–7255.
95. [95] Diamond, M.S., IFIT1: a dual sensor and effector molecule that detects non-2′-O methylated viral RNA and inhibits its translation. Cytokine Growth Factor Rev. 25 (2014), 543–550.
96. [96] Kusari, J., Sen, G.C., Transcriptional analyses of interferon-inducible mRNAs. Mol. Cell. Biol. 7 (1987), 528–531.
97. [97] Hui, D.J., Bhasker, C.R., Merrick, W.C., Sen, G.C., Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J. Biol. Chem. 278 (2003), 39,477–39,482.
98. [98] Terenzi, F., Hui, D.J., Merrick, W.C., Sen, G.C., Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J. Biol. Chem. 281 (2006), 34,064–34,071.
99. [99] Habjan, M., Hubel, P., Lacerda, L., Benda, C., Holze, C., Eberl, C.H., et al. Sequestration by IFIT1 impairs translation of 2′O-unmethylated capped RNA. PLoS Pathog., 9, 2013, e1003663.
100. [100] Kimura, T., Katoh, H., Kayama, H., Saiga, H., Okuyama, M., Okamoto, T., et al. Ifit1 inhibits Japanese encephalitis virus replication through binding to 5′ capped 2′-O unmethylated RNA. J. Virol. 87 (2013), 9997–10,003.
101. [101] Kumar, P., Sweeney, T.R., Skabkin, M.A., Skabkina, O.V., Hellen, C.U., Pestova, T.V., Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5′-terminal regions of cap0-, cap1- and 5′ppp- mRNAs. Nucleic Acids Res. 42 (2014), 3228–3245.
102. [102] Daffis, S., Szretter, K.J., Schriewer, J., Li, J., Youn, S., Errett, J., et al. 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468 (2010), 452–456.
103. [103] Szretter, K.J., Daniels, B.P., Cho, H., Gainey, M.D., Yokoyama, W.M., Gale, M. Jr., et al. 2′-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog., 8, 2012, e1002698.
104. [104] Dias, A., Bouvier, D., Crepin, T., McCarthy, A.A., Hart, D.J., Baudin, F., et al. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 458 (2009), 914–918.
105. [105] Wilusz, J., Putting an ‘end’ to HIV mRNAs: capping and polyadenylation as potential therapeutic targets. AIDS Res. Ther., 10, 2013, 31.
106. [106] Jang, S.K., Pestova, T.V., Hellen, C.U., Witherell, G.W., Wimmer, E., Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme 44 (1990), 292–309.
107. [107] Das, K., Arnold, E., Negative-strand RNA virus L proteins: one machine, many activities. Cell. 162 (2015), 239–241.
108. [108] Ogino, T., In vitro capping and transcription of rhabdoviruses. Methods 59 (2013), 188–198.
109. [109] Pauli, E.K., Chan, Y.K., Davis, M.E., Gableske, S., Wang, M.K., Feister, K.F., et al. The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25. Sci. Signal., 7, 2014, ra3.
110. [110] Castanier, C., Zemirli, N., Portier, A., Garcin, D., Bidere, N., Vazquez, A., et al. MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors. BMC Biol., 10, 2012, 44.
111. [111] Inn, K.S., Gack, M.U., Tokunaga, F., Shi, M., Wong, L.Y., Iwai, K., et al. Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. Mol. Cell 41 (2011), 354–365.
112. [112] Kanarek, N., London, N., Schueler-Furman, O., Ben-Neriah, Y., Ubiquitination and degradation of the inhibitors of NF-kappaB. Cold Spring Harb. Perspect. Biol., 2, 2010, a000166.
113. [113] Randow, F., Lehner, P.J., Viral avoidance and exploitation of the ubiquitin system. Nat. Cell Biol. 11 (2009), 527–534.
114. [114] Didcock, L., Young, D.F., Goodbourn, S., Randall, R.E., The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73 (1999), 9928–9933.
115. [115] Parisien, J.P., Lau, J.F., Horvath, C.M., STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J. Virol. 76 (2002), 6435–6441.
116. [116] Parisien, J.P., Lau, J.F., Rodriguez, J.J., Ulane, C.M., Horvath, C.M., Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J. Virol. 76 (2002), 4190–4198.
117. [117] Li, T., Chen, X., Garbutt, K.C., Zhou, P., Zheng, N., Structure of DDB1 in complex with a paramyxovirus V protein: viral hijack of a propeller cluster in ubiquitin ligase. Cell 124 (2006), 105–117.
118. [118] Angers, S., Li, T., Yi, X., MacCoss, M.J., Moon, R.T., Zheng, N., Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature 443 (2006), 590–593.
119. [119] Li, J., Wang, J.T., Whelan, S.P., A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 8493–8498.
120. [120] Bossert, B., Marozin, S., Conzelmann, K.K., Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J. Virol. 77 (2003), 8661–8668.
121. [121] Elliott, J., Lynch, O.T., Suessmuth, Y., Qian, P., Boyd, C.R., Burrows, J.F., et al. Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J. Virol. 81 (2007), 3428–3436.
122. [122] Ramage, H., Cherry, S., Virus-host interactions: from unbiased genetic screens to function. Annu. Rev. Virol. 2 (2015), 497–524.
123. [123] Panda, D., Das, A., Dinh, P.X., Subramaniam, S., Nayak, D., Barrows, N.J., et al. RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 19,036–19,041.
124. [124] Lee, A.S., Burdeinick-Kerr, R., Whelan, S.P., A genome-wide small interfering RNA screen identifies host factors required for vesicular stomatitis virus infection. J. Virol. 88 (2014), 8355–8360.
125. [125] Clemente, R., Sisman, E., Aza-Blanc, P., de la Torre, J.C., Identification of host factors involved in Borna disease virus cell entry through a small interfering RNA functional genetic screen. J. Virol. 84 (2010), 3562–3575.
126. [126] Cote, M., Misasi, J., Ren, T., Bruchez, A., Lee, K., Filone, C.M., et al. Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection. Nature 477 (2011), 344–348.
127. [127] Wu, B., Peisley, A., Richards, C., Yao, H., Zeng, X., Lin, C., et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152 (2013), 276–289.